DBV Technologies SA (DBV.PA)

DBV.PA on Paris Stock Exchange

35.74EUR
11:35am EDT
Price Change (% chg)

€-0.42 (-1.16%)
Prev Close
€36.16
Open
€36.10
Day's High
€39.85
Day's Low
€35.12
Volume
259,493
Avg. Vol
90,137
52-wk High
€40.00
52-wk Low
€8.40

DBV.PA

Chart for DBV.PA

About

DBV Technologies SA is a France-based company focused on the development of products for the diagnosis and treatment of food allergies. The Company’s products are designed to deliver on intact skin allergens against food allergies and for allergy diagnosis. The antigens (allergens) are delivered to the skin using DBV Technologie... (more)

Overall

Beta: --
Market Cap (Mil.): €555.90
Shares Outstanding (Mil.): 15.37
Dividend: --
Yield (%): --

Financials

  DBV.PA Industry Sector
P/E (TTM): -- 32.90 33.54
EPS (TTM): -1.78 -- --
ROI: -67.71 18.34 17.61
ROE: -71.28 19.01 18.42
Search Stocks

French developer of 'peanut allergy patch' makes U.S. debut

PARIS - French biotech firm DBV Technologies - developer of what it says is a breakthrough treatment for peanut allergy sufferers - makes its U.S. market debut on Wednesday, with a Nasdaq listing set to raise funds for further research.

4:09am EDT

French developer of "peanut allergy patch" makes U.S. debut

PARIS, Oct 22 - French biotech firm DBV Technologies - developer of what it says is a breakthrough treatment for peanut allergy sufferers - makes its U.S. market debut on Wednesday, with a Nasdaq listing set to raise funds for further research.

4:06am EDT

BRIEF-DBV Technologies announces pricing of global offering

* Offering price to public of $21.64 per ADS in United States, Canada and countries outside of France

2:33am EDT

BRIEF-DBV Technologies announces proposed global offering for 2.67 mln shares

* It intends to offer and sell, subject to market and other conditions, up to 2,673,641 of its ordinary shares in a global offering

20 Oct 2014

BRIEF-DBV Technologies nine month total income rises to 3.9 mln euros

* For the first nine months of 2014, total income reached 3,914,707 euros, up from 2,535,963 euros last year

14 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks